Healthcare provider profile · identity verified

Arunima Dutta, MD

Internal Medicine · PORT ORCHARD, WA · NPI 1033605951

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	430	133
Levothyroxine Sodium	Levothyroxine Sodium	307	99
Losartan Potassium	Losartan Potassium	288	88
Amlodipine Besylate	Amlodipine Besylate	258	81
Gabapentin	Gabapentin	258	88
Lisinopril	Lisinopril	219	74
Omeprazole	Omeprazole	150	49
Rosuvastatin Calcium	Rosuvastatin Calcium	147	48
Pantoprazole Sodium	Pantoprazole Sodium	137	45
Trazodone Hcl	Trazodone Hcl	133	46
Albuterol Sulfate Hfa	Albuterol Sulfate	130	44
Metoprolol Succinate	Metoprolol Succinate	129	42
Metformin Hcl	Metformin Hcl	127	49
Hydrochlorothiazide	Hydrochlorothiazide	121	36
Carvedilol	Carvedilol	116	31
Alendronate Sodium	Alendronate Sodium	109	40
Duloxetine Hcl	Duloxetine Hcl	103	35
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	101	49
Sertraline Hcl	Sertraline Hcl	100	28
Meloxicam	Meloxicam	99	36
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	97	31
Simvastatin	Simvastatin	96	35
Famotidine	Famotidine	94	22
Oxybutynin Chloride Er	Oxybutynin Chloride	74	24
Tamsulosin Hcl	Tamsulosin Hcl	74	26
Tizanidine Hcl	Tizanidine Hcl	66	19
Zolpidem Tartrate	Zolpidem Tartrate	65	21
Oxycodone Hcl	Oxycodone Hcl	64	26
Fluoxetine Hcl	Fluoxetine Hcl	62	21
Bupropion Xl	Bupropion Hcl	60	20
Escitalopram Oxalate	Escitalopram Oxalate	60	19
Buspirone Hcl	Buspirone Hcl	58	19
Pregabalin	Pregabalin	58	19
Ezetimibe	Ezetimibe	56	19
Estradiol	Estradiol	54	20
Tramadol Hcl	Tramadol Hcl	53	20
Allopurinol	Allopurinol	52	18
Alprazolam	Alprazolam	50	22
Metformin Hcl Er	Metformin Hcl	48	16
Sumatriptan Succinate	Sumatriptan Succinate	48	suppressed
Ondansetron Odt	Ondansetron	47	22
Xarelto	Rivaroxaban	47	19
Citalopram Hbr	Citalopram Hydrobromide	46	17
Clonazepam	Clonazepam	46	12
Potassium Chloride	Potassium Chloride	44	23
Furosemide	Furosemide	43	21
Clopidogrel	Clopidogrel Bisulfate	42	14
Fluticasone Propionate	Fluticasone Propionate	42	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	42	15
Topiramate	Topiramate	42	16
Venlafaxine Hcl Er	Venlafaxine Hcl	42	12
Eliquis	Apixaban	41	18
Hydroxyzine Hcl	Hydroxyzine Hcl	41	17
Lorazepam	Lorazepam	40	13
Chlorthalidone	Chlorthalidone	39	suppressed
Lovastatin	Lovastatin	39	suppressed
Montelukast Sodium	Montelukast Sodium	38	11
Ozempic	Semaglutide	37	13
Pravastatin Sodium	Pravastatin Sodium	36	suppressed
Warfarin Sodium	Warfarin Sodium	36	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	35	12
Metoprolol Tartrate	Metoprolol Tartrate	35	13
Ventolin Hfa	Albuterol Sulfate	35	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	31	suppressed
Synthroid	Levothyroxine Sodium	31	12
Hydralazine Hcl	Hydralazine Hcl	30	suppressed
Jardiance	Empagliflozin	30	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	30	suppressed
Mirtazapine	Mirtazapine	29	suppressed
Myrbetriq	Mirabegron	29	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	28	11
Lamotrigine	Lamotrigine	28	suppressed
Methocarbamol	Methocarbamol	28	suppressed
Baclofen	Baclofen	27	suppressed
Benazepril Hcl	Benazepril Hcl	27	suppressed
Ropinirole Hcl	Ropinirole Hcl	27	suppressed
Trulicity	Dulaglutide	26	suppressed
Aripiprazole	Aripiprazole	25	suppressed
Liothyronine Sodium	Liothyronine Sodium	25	suppressed
Fondaparinux Sodium	Fondaparinux Sodium	24	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	24	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	24	21
Spironolactone	Spironolactone	24	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	11
Nitroglycerin	Nitroglycerin	23	15
Acyclovir	Acyclovir	22	13
Finasteride	Finasteride	22	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	21	suppressed
Prednisone	Prednisone	21	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Celecoxib	Celecoxib	20	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Glipizide Er	Glipizide	20	suppressed
Mounjaro	Tirzepatide	20	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	20	suppressed
Spiriva Handihaler	Tiotropium Bromide	20	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	19	suppressed
Clobetasol Propionate	Clobetasol Propionate	18	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Temazepam	Temazepam	18	suppressed
Diclofenac Sodium	Diclofenac Sodium	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	suppressed
Meclizine Hcl	Meclizine Hcl	17	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	17	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	16	suppressed
Ipratropium Bromide	Ipratropium Bromide	16	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	16	12
Atenolol	Atenolol	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Prazosin Hcl	Prazosin Hcl	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Trintellix	Vortioxetine Hydrobromide	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	14	suppressed
Carvedilol Er	Carvedilol Phosphate	13	suppressed
Dantrolene Sodium	Dantrolene Sodium	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Glycopyrrolate	Glycopyrrolate	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	12	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	11	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Bupropion Hcl	Bupropion Hcl	11	suppressed
Diazepam	Diazepam	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Potassium Citrate Er	Potassium Citrate	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	11	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error